Duloxetine
Product Images NDC 50090-2585

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-2585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)
FDA Label Image

Fig2 (Duloxetine Fig2)

Fig2 (Duloxetine Fig2)
FDA Label Image

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)
FDA Label Image

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)
The text is a graph showing the percentage of patients improved based on the level of pain improvement from baseline after taking Duloxetine 60mg twice a day, Duloxetine 60mg once a day, or placebo. The x-axis shows the percent improvement in pain from baseline while the y-axis shows the percentage of patients improved.*
FDA Label Image

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)
The text is a chart showing the percentage of patients' improvement in pain from baseline with Duloxetine 60 mg twice daily, Duloxetine 60 mg once daily, and placebo. It also shows the percentage improvement in pain at different levels from baseline.*
FDA Label Image

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)
The text appears to be a chart or graph displaying different dosages of a medication called Duloxetine and the percentage of patients who experienced pain improvement from baseline. The chart shows that the higher the dosage of Duloxetine, the greater the percentage of patients who experienced improvement in pain. However, it is difficult to interpret the chart fully without additional context.*
FDA Label Image

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)
This is a chart that displays the percentage of patients who experienced improvement in pain from baseline after receiving either a placebo or Duloxetine 60/120 mg once. The results are represented using a scale from 0 to 100, with 0 being no improvement and 100 being full improvement. The chart also includes a line graph showing the percent improvement in pain over time, with data points at specific time intervals.*
FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
This is a chart that shows the percentage of patients who experienced improvement in pain after taking a placebo or duloxetine (at a dosage of 60mg once daily) over a period of time. The chart also shows a scale of percent improvement in pain from baseline (BOCF) ranging from 0 to 100.*
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
This appears to be a graph showing the percentage improvement of pain from baseline while using the medication Duloxetine at a dose of 60 or 120 mg once daily. However, without more context or clearer visuals it may be difficult to interpret the data accurately.*
FDA Label Image

Structure (Duloxetine Str)

Structure (Duloxetine Str)
FDA Label Image

Label Image (Lbl500902585)

Label Image (Lbl500902585)
Product No. 6492-0 is a box of 30 delayed-release capsules containing 60mg of Duloxetine, a medication commonly used to treat depression, anxiety, and chronic pain. It should be stored at a temperature of 68 to 77 degrees Fahrenheit (20 to 25 degrees Celsius).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.